RXI PHARMACEUTICALS CORP NEW
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for RXI PHARMACEUTICALS CORP NEW *W EXP 12/16/202, CUSIP 74979C121.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for RXI PHARMACEUTICALS CORP NEW *W EXP 12/16/202, CUSIP 74979C121.